InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| AddaVax™ | Incorporation of SARS-CoV-2 spike NTD to RBD Protein Vaccine Improves Immunit... | 2023 | iScience | Montgomerie I. et al. | DOI: 10.1016/j.isci.2023.106256 |
| Omicron Variant (B.1.1.529/BA.1) Spike Pseudotyping Vector | Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effect... | 2023 | Curr Issues Mol Biol. | Santos da Silva E. et al. | DOI: 10.3390/cimb45020112 |
| Omicron Variant (BA.2) Spike Pseudotyping Vector | Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effect... | 2023 | Curr Issues Mol Biol. | Santos da Silva E. et al. | DOI: 10.3390/cimb45020112 |
| Primocin® | Establishment of an Inactivation Method for Ebola Virus and SARS-CoV-2 Suitab... | 2023 | Pathogens | Olejnik J. et al. | DOI: 10.3390/pathogens12020342 |
| AddaVax™ | CDK4/6 inhibitor palbociclib promotes SARS-CoV-2 cell entry by down-regulatin... | 2023 | Antiviral Res. | Xiao Y. et al. | DOI: 10.1016/j.antiviral.2023.105558 |
| QUANTI-Blue™ | TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signalin... | 2023 | Int Immunopharmacol | Sun X. et al. | DOI: 10.1016/j.intimp.2023.109852 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signalin... | 2023 | Int Immunopharmacol | Sun X. et al. | DOI: 10.1016/j.intimp.2023.109852 |
| TLR4-based adjuvant - MPLA-SM VacciGrade™ | TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signalin... | 2023 | Int Immunopharmacol | Sun X. et al. | DOI: 10.1016/j.intimp.2023.109852 |
| G418 (Geneticin) | Effects of all-trans and 9-cis retinoic acid on differentiating human neural ... | 2023 | Toxicology | Kubickova B. et al. | DOI: 10.1016/j.tox.2023.153461 |
| Imiquimod (R837) | Brexanolone therapeutics in post-partum depression involves inhibition of sys... | 2023 | EBioMedicine | Balan I. et al. | DOI: 10.1016/j.ebiom.2023.104473 |
| Primocin® | Generation of an induced pluripotent stem cell (iPSC) line of a Marfan syndro... | 2023 | Stem Cell Res. | Peeters S. et al. | DOI: 10.1016/j.scr.2023.103050 |
| LPS-EB VacciGrade™ | Immunomodulatory Effects of Bacterial Toll-like Receptor Ligands on the Pheno... | 2023 | Biology (Basel) | Hussen J. et al. | DOI: 10.3390/biology12020276 |
| PlasmoTest™ - Mycoplasma Detection Kit | Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene ... | 2023 | Cancers (Basel) | Taylor L. et al. | DOI: 10.3390/cancers15041086 |
| LC3B-GFP | Heterogeneity of Amino Acid Profiles of Proneural and Mesenchymal Brain-Tumor... | 2023 | Int J Mol Sci. | Seliger C. et al. | DOI: 10.3390/ijms24043199 |
| Primocin® | Efficient Establishment of Bile-Derived Organoids From Patients With Biliary ... | 2023 | Lab Invest. | Kinoshita K. et al. | DOI: 10.1016/j.labinv.2023.100105 |
| Jurkat-Dual™ Cells | Water channel aquaporin 4 is required for T cell receptor mediated lymphocyte... | 2023 | J Leukoc Biol. | Nicosia M. et al. | DOI: 10.1093/jleuko/qiad010 |
| Jurkat Reporter Cells (NFAT) | Water channel aquaporin 4 is required for T cell receptor mediated lymphocyte... | 2023 | J Leukoc Biol. | Nicosia M. et al. | DOI: 10.1093/jleuko/qiad010 |
| Human CD28 Jurkat Reporter Cells (NFAT) | Water channel aquaporin 4 is required for T cell receptor mediated lymphocyte... | 2023 | J Leukoc Biol. | Nicosia M. et al. | DOI: 10.1093/jleuko/qiad010 |
| QUANTI-Luc™: Luciferase Detection Reagent | Water channel aquaporin 4 is required for T cell receptor mediated lymphocyte... | 2023 | J Leukoc Biol. | Nicosia M. et al. | DOI: 10.1093/jleuko/qiad010 |
| Pan-Caspase inhibitor - Z-VAD-FMK | ATG16L1 protects from IFN-γ-induced cell death in the small intestinal crypt. | 2023 | Mucosal Immunol. | Foerster E.G. et al. | DOI: 10.1016/j.mucimm.2023.02.001 |